#Néovacs tiendra une conférence téléphonique aujourd'hui à 10h00.am CEST, suivez en direct la présentation via le lien suivant : bit.ly/2NlTCRC

#Neovacs will hold a Webcast conference call today at 10:00 am CEST, log in via the following link: bit.ly/2NlTCRC

[VIDEO] Interview de Miguel SIELER, Directeur Général de Néovacs boursier.com/actions/actual… via Boursier.com

French Lupus Vaccine Ready to Move Into Phase III labiotech.eu/neovacs-lupus-…

Réécoutez l’ITW de Miguel Sieler, directeur général de #Neovacs - diffusée en direct sur BFMBusiness le 04/07 à 16h bfmbusiness.bfmtv.com/mediaplayer/vi… via @BFMBusiness

Get to Know 15 Awesome Biotechs in Paris labiotech.eu/15-awesome-bio…

Neovacs’ Investigational Lupus Vaccine Shows Positive Results in Phase 2b Trial lupusnewstoday.com/2018/07/11/neo…

Miguel Sieler Directeur Général Neovacs SA invité de Didier Testot ⭐️⭐️🇫🇷 LA BOURSE ET LA VIE TV ⭐️⭐️ "Nous sommes dans le trio de tête des entreprises dans le développement clinique pour le lupus". #Biotech labourseetlavie.com/strategie-et-r…

Neovacs to attend the 13th International Congress on Systemic Lupus Erythematosus in San Francisco, California, April 5-8 2019 #LupusCongress #Lupus2019 #Lupus #Congress #SanFrancisco

Le Journal des Biotechs@: Interview Miguel Sieler, CEO de Neovacs bit.ly/2UY18EO

It’s been quite a month! Filled with stories of hope from researchers, advocates and people with lupus. Thank you for all you do to help advance lupus research! With your continued support, we will continue keeping up the momentum all year long! #LupusAwarenessMonth

#neovacs to present the pre-clinical results of IFNalpha Kinoid to treat Type 1 Diabetes at #ADA2019 bit.ly/2ImG32t

Neovacs presented its Type 1 diabetes project using IFN-K vaccine American Diabetes Association - DiabetesPro scientific session

Le Dr. Virginia Pascual rejoint Neovacs #nomination #clinicalresearch #lupus bit.ly/2NqKHlM

#Neovacs announces appointment of Dr. Virginia Pascual bit.ly/2IR6oau #lupus #clinicalresearch #NewsUpdate

What is lupus? Watch as #MacktheMolecule breaks it down. #whatislupus #lupus #lupusvideo #SLE #autoimmune #breakingthrough #preventlupus #treatlupus #curelupus

Good News for IFNalpha targeting approaches to halt lupus disease

NEW RESEARCH: LLDAS (#Lupus low disease activity state) attainment is associated with significant protection against flare and damage accrual in #SLE thelancet.com/journals/lanrh… #LancetRheumatology

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study bit.ly/2lKdTa0